Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer

Application of doxorubicin (Dox) for the treatment of cancer is restricted due to its severe side effects. We used combination strategy by combining doxorubicin (Dox) with withaferin A (WFA) to minimize the ill effects of Dox. Treatment of various epithelial ovarian cancer cell lines (A2780, A2780/C...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Miranda Y., Jin, Shunying, Rane, Madhavi, Singh, Raj K., Gupta, Ramesh, Kakar, Sham S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408484/
https://www.ncbi.nlm.nih.gov/pubmed/22860102
http://dx.doi.org/10.1371/journal.pone.0042265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408484/
https://www.ncbi.nlm.nih.gov/pubmed/22860102
http://dx.doi.org/10.1371/journal.pone.0042265

Ejemplares similares